I would also appreciate if someone with more knowledge in the HepC field to post some concrete Data regarding Medivir's ASPIRE Phase IIb Trial. It would be also interesting to see what Medivir Abstracts look like. Medivir has commenced Phase III testing of TMC435. So if someone has the Data sheet from the ASPIRE Phase IIB vs ACH-1625 in Phase 2a; I would like to see the charts comparison. Thanks!